Harvard Business Review

JUNE 9, 2017

Few issues are more foundational to driving improvements in human health than creating productive, progressive relationships between clinical medicine and the biopharmaceutical industry. During our careers, we have worked in industry, academia, clinical medicine, and government and have managed successful academia-industry collaborations.

Conflict of Interest 10

Conflict of Interest Pharmaceuticals Policies Industry 10

Harvard Business Review

APRIL 2, 2018

There is an abundance of high-quality comparative effectiveness data for pharmaceuticals, largely because of the drug approval process, but there’s less data on the value of other expensive investments into health, such as doctor visits and hospitalizations. (For

Health Care 8

Health Care Insurance Pharmaceuticals Incentives 8

Harvard Business Review

SEPTEMBER 21, 2015

Not long ago, I worked with a client who was stepping into management for the first time. Terry, a highly regarded marketing associate in a pharmaceutical firm, had just been asked to lead a marketing team. They just weren’t putting together a high-quality product. Managing Yourself Book. Further Reading.

Management 8

Management Pharmaceuticals Learning-by-Doing Marketing 8

Harvard Business Review

JANUARY 10, 2013

initiative — prohibitions against off-label marketing under the False Claims Act — swept through the pharmaceutical industry. The most notable was Fannie Mae's $10.8 billion restatement. In another instance, a new enforcement. The largest payments were from Pfizer ($2.3 billion) and GlaxoSmithKline ($3 billion).

Finance 8

Finance Banking Press Release Pharmaceuticals 8

Harvard Business Review

OCTOBER 13, 2011

Risk management processes don't — but they should. The pharmaceutical industry also creates products with complex interactions and potentially dangerous side effects. Yet unlike in finance, where distributing risk across institutions is the goal, in drug development the focus is on isolating risk.

Banking 10

Banking Pharmaceuticals Microfinance Risk Management 10

Harvard Business Review

OCTOBER 25, 2018

We focus on economic profit rather than revenue size, market share, or productivity growth because these other metrics risk including firms that are simply large and may not create economic value. Productivity can help; but it is not enough to achieve superstardom.

Industry 12

Industry Company GDP Bottom-up 12

Harvard Business Review

OCTOBER 20, 2016

Imports among the world’s 20 largest economies have fallen as a share of their gross domestic product for four consecutive years. Meanwhile the Institute of International Finance forecasted net capital flows for emerging markets in 2015 would be negative for the first time since 1988. at the forefront.

Globalization 8

Globalization Banking Policies Politics 8

Harvard Business Review

AUGUST 2, 2011

In reality, each country needs the other to succeed in order to thrive — to finance growth, secure export markets, train talent, transfer technology, and more. For example, pharmaceutical firms license compounds to each other and co-promote products in different markets.

Apparel 15

Apparel Pharmaceuticals Finance Licensing 15

Harvard Business Review

JUNE 16, 2016

Pharmaceutical companies spend millions upon millions preparing meticulous plans for new drug launches – and yet their route-to-market strategies haven’t changed in decades, even though the reality of the market has. We must start to think differently about how business, management, and strategic intelligence works.

Planning 8

Planning Competitive Intelligence Pharmaceuticals Brand 8

Harvard Business Review

NOVEMBER 20, 2015

One result is that they keep their cards close to their chests about what they are looking for (at first), while expecting you to reveal everything – your finances, pricing, ownership, human resources, production processes, quality assurance, customer service procedures, KPIs, and existing customers.

Supply Chain 8

Supply Chain Collins Golden Handcuff Pharmaceuticals 8

Harvard Business Review

APRIL 19, 2016

Imagine the changes afoot in the pharmaceutical, medical device, automotive, and consumer electronics industries. For example, printing products on demand would significantly reduce the U.S. What happens, for example, if the value of a product’s underlying intellectual property overtakes its production value?

Supply Chain 8

Supply Chain Execution Analysis Technology 8

Harvard Business Review

JANUARY 26, 2016

We recently conducted a survey of CI managers and analysts who’ve been through our training program to see how much their findings influenced major company decisions, and why. and European corporations, from CI-trained analysts in marketing, business development, strategy, R&D, finance, and other fields.

Competitive Intelligence 8

Competitive Intelligence Company CAPEX Analysis 8

Harvard Business Review

JUNE 8, 2015

Pharmaceutical companies, buffeted by regulatory changes, new drug technologies that alter entry barriers and competition, price pressures, and an estimated 300,000 job cuts since 2000, seem to fit the popular narrative of large organizations unable to deal with disruptive forces. It’s not just products. Experimentation is vital.

Health Care 8

Health Care Venture Capitalist Strategic Fit Pharmaceuticals 8

Harvard Business Review

NOVEMBER 9, 2011

That's what we found when we studied the top management teams of companies in Europe over the past three years. Part of the problem may be in the backgrounds that companies desired: 85% of COOs had experience in operations, strategy, or finance. What role does he or she play in the organization?

COO 12

COO Sample Telecommunications Automotive 12

Harvard Business Review

SEPTEMBER 5, 2016

Pearson, the educational publisher, measures the efficacy of its products to improve educational outcomes. Cigna is the first insurance company to get pharmaceutical companies to agree to value pricing based on results for certain cholesterol-lowering drugs. ” Health care. ” Health care. Required Capabilities.

Incentives 8

Incentives Health Care Education Insurance 8

Harvard Business Review

JUNE 29, 2015

If you ask someone who works in finance (as I had to) about PE and innovation, he or she will likely tell you that PE sponsors aren’t looking for the next big thing—they’re looking for companies that are dominant in a market, aren’t risky, and have a predictable and steady stream of cash to pay back debt.

LBO 8

LBO Innovation Sample Short-term 8

Harvard Business Review

SEPTEMBER 10, 2013

A good idea faces so many obstacles en route to market today that it''s a wonder we have any innovative products at all. And corporate venture funds, if well managed, can avoid the fickleness problem that plagues independent venture capital and crowdfunding. Finance Innovation' It''s like that. Innovation Isn''t an Idea Problem.

Venture Capitalist 8

Venture Capitalist Venture Funding Innovation Incentives 8

Harvard Business Review

SEPTEMBER 10, 2013

A good idea faces so many obstacles en route to market today that it’s a wonder we have any innovative products at all. And corporate venture funds, if well managed, can avoid the fickleness problem that plagues independent venture capital and crowdfunding. Finance Innovation Insight Center_Innovation no-intromercial'

Venture Capitalist 8

Venture Capitalist Venture Funding Innovation Incentives 8

Harvard Business Review

AUGUST 23, 2012

For highly regulated sectors like finance, social media can be a legal minefield. These hurdles aren't unique to financial services — insurance, pharmaceuticals, health care and government all face regulation, to name a few examples. "Follow us here for updates on our work, our research, and our people.".

Compliance 15

Compliance Media Compliance Officer Policies 15

Harvard Business Review

APRIL 5, 2012

A district sales manager says: "These district sales rankings are unfair. This allowed the business to grow sales productivity by 7 percent and give back a budgeted $2 million for additional headcount — the productivity improvements allowed the sales organization to meet growth goals without adding people. Deduce the data.

Retail 9

Retail Incentives Tactics Pharmaceuticals 9

Harvard Business Review

SEPTEMBER 13, 2011

Here are some common examples: When pharmaceutical companies announce that a new drug has been "approved," they are actually saying that their researchers made some breakthrough discoveries as far back as fifteen years ago.

Short-term 14

Short-term Pharmaceuticals Long-term Maturity 14

Harvard Business Review

MAY 5, 2016

The country’s urbanized and large middle class has maintained a strong preference for foreign-made products despite restrictions due to U.S. There are some exemptions for humanitarian-designated sectors, such as agriculture, food products, health care, and civil aviation.). sanctions are delaying these projects being financed.

Tourism 8

Tourism Banking Due Diligence Hotels 8

Harvard Business Review

FEBRUARY 24, 2015

Conversely, the business may be an “unpolished diamond” that was neglected by its former management for too long and whose value is just waiting to be unlocked. Does the business have a complete, balanced, and cohesive management team? Are the management team and owners prepared to abandon business as usual?

Chemicals 8

Chemicals How To Kahneman Reputation 8

Harvard Business Review

FEBRUARY 20, 2014

But an awful lot of these jobs command very high-wages in law, finance, accounting, consulting, advertising, engineering, design, software, healthcare, scientific research, architecture, entertainment, hospitality, and many other areas. Since then, America’s productivity lead has been growing sharply, not falling behind. Far from it.

Intellectual Capital 8

Intellectual Capital Magazine Pharmaceuticals Creativity 8

Harvard Business Review

MAY 15, 2013

In large part, culture is a product of compensation." — Alec Haverstick. Are patterns of behavior the product of incentives, or have incentives been shaped in fundamental ways by beliefs and values that underpin the culture? finance vs. marketing) and units (e.g. Culture is powerfully shaped by incentives.

Incentives 8

Incentives Definition Pharmaceuticals System 8

Harvard Business Review

FEBRUARY 26, 2013

For sales managers, this is not an easy question to answer. But when leaders take this conservative growth approach even when there is reasonable certainty of success and available financing, they undersize their sales forces and forfeit opportunity. The number of salespeople affects profitably by impacting both revenues and costs.

Company 8

Company Short-term Long-term Cost 8

Harvard Business Review

FEBRUARY 4, 2013

Levi Strauss, intriguingly, has used biomimetic techniques in developing new production techniques for jeans. Perhaps surprisingly, two leading examples come from pharmaceutical companies. Breakthrough Finance. Breakthrough Activism. Breakthrough involves a shift to new types of impact investment.

EPS 8

EPS Innovation CEO Pharmaceuticals 8

Harvard Business Review

JUNE 20, 2017

For example, a key source of concern for some companies is more-restrictive rules of origin, which would reduce the amount of materials allowed to be used tariff-free for products traded to and from NAFTA member countries. So, if a company manufactures products in Mexico to export to Canada and the U.S.

Supply Chain 8

Supply Chain Depreciation Uncertainty Marketing 8

Harvard Business Review

JANUARY 4, 2017

There are similar stories in the electronics industry, pet food, pharmaceuticals, and even national security. This regulation came as a result of concerns that the exploitation and trade of conflict minerals by armed groups was helping to finance conflict in the DRC region and contributing to its emergency humanitarian crisis.

Supply Chain 9

Supply Chain Productivity Products Company 9

Harvard Business Review

AUGUST 23, 2016

Both Republicans and Democrats say the most effective board committee is audit/finance. Meanwhile, Democrats place greater importance on technology expertise and risk management. food, beverage & tobacco, household and personal products); Energy & Utilities (e.g.,

Politics 8

Politics Committee Telecommunications Diversity 8